General Court 17 November 2017, Case T-802/16: Judgment of the General Court of 17 November 2017 — Endoceutics v EUIPO — Merck (FEMIBION) (EU trade mark — Revocation proceedings — EU word mark FEMIBION — Partial revocation — Article 51(1)(a) of Regulation (EC) No 207/2009 (now Article 58(1)(a) of Regulation (EU) 2017/1001) — Proof of genuine use of the mark — Classification of the goods in respect of which genuine use has been shown)
Also known as
European Union · · · 17-11-2017
8.1.2018 EN Official Journal of the European Union C 5/40 Judgment of the General Court of 17 November 2017 — Endoceutics v EUIPO — Merck (FEMIBION) (Case T-802/16) (1) ((EU trade mark - Revocation proceedings - EU word mark FEMIBION - Partial revocation - Article 51(1)(a) of Regulation (EC) No 207/2009 (now Article 58(1)(a) of Regulation (EU) 2017/1001) - Proof of genuine use of the mark -
Read the full text
This document is published by eur-lex.europa.eu.
Moonlit adds the citation network, article-level links and cross-references, which are available to search for free.
Sign in to Moonlit